LTR Pharma
Clinical-stage biopharmaceutical company based in Brisbane, Australia, focused on development and commercialisation of an intranasal drug-delivery platform for PDE5 inhibition intended to treat erectile dysfunction. Activities include formulation and manufacturing development for intranasal delivery, clinical pharmacokinetic and bioequivalence studies, regulatory pathway progression (including FDA 505(b)(2) strategy and TGA special access engagement), and commercial distribution partnerships in Australia.
Industries
Nr. of Employees
small (1-50)
LTR Pharma
Products
Intranasal PDE5 inhibitor spray (lead product)
An intranasal formulation of a PDE5 inhibitor developed for rapid onset of action and reduced systemic exposure compared with oral tablets; advanced through proof-of-concept and bioequivalence study planning for regulatory submission.
Intranasal spray development for oesophageal motility disorders (development project)
Development program to adapt intranasal delivery technology to provide rapid symptom relief for oesophageal motility disorders.
Intranasal PDE5 inhibitor spray (lead product)
An intranasal formulation of a PDE5 inhibitor developed for rapid onset of action and reduced systemic exposure compared with oral tablets; advanced through proof-of-concept and bioequivalence study planning for regulatory submission.
Intranasal spray development for oesophageal motility disorders (development project)
Development program to adapt intranasal delivery technology to provide rapid symptom relief for oesophageal motility disorders.
Services
Co-development collaborations for intranasal products
Collaborative development agreements with external formulation and device partners to develop intranasal spray products for multiple clinical indications.
National pharmacy distribution via third-party wholesaler
Distribution, warehousing and inventory management through a national pharmaceutical wholesaler to supply community pharmacies.
Co-development collaborations for intranasal products
Collaborative development agreements with external formulation and device partners to develop intranasal spray products for multiple clinical indications.
National pharmacy distribution via third-party wholesaler
Distribution, warehousing and inventory management through a national pharmaceutical wholesaler to supply community pharmacies.
Expertise Areas
- Intranasal drug delivery
- Clinical trial management and bioequivalence studies
- Pharmacokinetics and bioavailability assessment
- Formulation development for transmucosal absorption
Key Technologies
- Intranasal drug delivery
- Transmucosal absorption-enhanced formulations
- Pharmacokinetic (PK) analysis
- Bioequivalence study design